HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases

SIMPLE SUMMARY: Dysregulated angiogenesis contributes to cancer progression and to many chronic inflammatory diseases. Many efforts in the field of angiogenesis have been made to discover new potential molecular targets to be used as biomarkers or to improve the anti-angiogenic therapies. HIPK2, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Garufi, Alessia, D’Orazi, Valerio, Pistritto, Giuseppa, Cirone, Mara, D’Orazi, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000595/
https://www.ncbi.nlm.nih.gov/pubmed/36900356
http://dx.doi.org/10.3390/cancers15051566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000595/
https://www.ncbi.nlm.nih.gov/pubmed/36900356
http://dx.doi.org/10.3390/cancers15051566

Ejemplares similares